CREB3 and neoplasm: TACE-induced tumor localized ischemia and hypoxia trigger CREB3 activation, subsequently upregulating M17 module (stemness/metastasis) gene expression, enabling scPAS + cells to tolerate treatment-induced damage while maintaining tumor progression capacity.